gms | German Medical Science

83rd Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery

16.05. - 20.05.2012, Mainz

Article

Send article

Results of the therapy of pT1/pT2 floor of the mouth cancer

Meeting Abstract

Search Medline for

  • corresponding author Julian Künzel - Univ. HNO-Klinik, Erlangen, Germany
  • presenting/speaker Georgios Psychogios - Univ. HNO-Klinik, Erlangen, Germany
  • presenting/speaker Michael Koch - Univ. HNO-Klinik, Erlangen, Germany
  • presenting/speaker Heinrich Iro - Univ. HNO-Klinik, Erlangen, Germany
  • presenting/speaker Konstantinos Mantsopoulos - Univ. HNO-Klinik, Erlangen, Germany
  • presenting/speaker Frank Waldfahrer - Univ. HNO-Klinik, Erlangen, Germany

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. 83rd Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. Mainz, 16.-20.05.2012. Düsseldorf: German Medical Science GMS Publishing House; 2012. Doc12hno19

doi: 10.3205/12hno19, urn:nbn:de:0183-12hno198

Published: July 23, 2012

© 2012 Künzel et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.

Outline

Text

Introduction: Early floor of the mouth cancer is primarily treated surgically. It is generally accepted that a risk of occult cervical metastases >20% is an indication for elective neck dissection (ND). The goal of this paper was to report about the results of primary surgical treatment and to prove the benefit of an elective ND in the clinically negative neck (cN0).

Methods: A retrospective analysis was carried out, including 216 patients (median age: 52.9), who were treated between 1980 and 2010 due to a pT1/2 floor of the mouth cancer (pT1, n=122; pT2: n=94). The 5-year disease specific survival (DSS) according to Kaplan- Meier and the locoregional tumor control (LRC) according to T- and N- classification was investigated.

Results: In 209 cases a R0 resection (R0 in pT1: n=119; R0 in pT2: n=90) and in 5 cases a R1 status was achieved (Rx: n=2). In 165 patients a ND was performed. In 124 cases an adjuvant therapy was carried out. 90 patients were staged cN0 (pT1: n=62; pT2: n=28) and in 48 of these cases (pT1: n=29; pT2: n=19) an elective ND was performed. The risk of occult metastases was 3.4% (pN1: n=1) in case of pT1 and 26.3% (pN1: n=4; pN2: n=1) in case of pT2. DSS of all patients was 79.5%, LRC 89.8%. DSS of 84.6% for pN0 was significantly higher than a DSS of 60% in case of pN+ (p=0.001). The T- status showed significant impact on DSS (pT1=86.5% and pT2=70.9%; p=0.002).

Conclusion: The primarily surgical treatment of pT1/pT2 floor of the mouth cancer provides acceptable oncologic results. In pT2 cancer a standardized ND should be carried out. In case of pT1 the clinical negative neck can be managed by a wait and scan strategy.